Casdatifan Targets HIF-2α in Kidney Cancer With Once-Daily Oral Dosing
For the roughly 75,000 Americans diagnosed with kidney cancer annually, treatment options for the most common subtype — clear cell renal cell carcinoma — have…
Found 1715 results for "cancer"
For the roughly 75,000 Americans diagnosed with kidney cancer annually, treatment options for the most common subtype — clear cell renal cell carcinoma — have…
For the millions of cancer patients who relapse after treatment, the culprit is increasingly traced not to the bulk tumor but to a resilient subpopulation of…
Copper is one of biology's most paradoxical minerals — essential in trace amounts yet lethal when it accumulates in the wrong cellular compartment. A…
Understanding exactly how lipid signaling molecules commandeer cellular machinery has profound implications for drug design targeting inflammation, pain…
Castration-resistant prostate cancer represents one of the most lethal clinical endpoints in oncology, affecting tens of thousands of men annually who have…
Glioblastoma remains one of the most treatment-resistant cancers, with median survival under 15 months even with aggressive therapy. A newly identified…
Most adults assume cancer appears suddenly, but mounting evidence reveals that certain blood cancers incubate silently for decades through a process called…
Brain metastases represent one of oncology's most intractable challenges — not because they are rare, but because even the best available interventions remain…
For men whose prostate cancer has become impervious to hormone therapy, treatment options narrow dramatically — and the molecular reasons why have remained…
Cancer treatment strategies built on destabilizing tumor chromosomes may be more complicated than previously assumed — and understanding why could reshape how…
As precision oncology increasingly captures headlines, a quieter revolution in cancer treatment is raising an urgent question that clinicians and payers alike…
For the millions of women with metastatic breast cancer, knowing whether a targeted therapy is actually reaching and killing tumor cells — in real time…
A computational re-examination of 45,454 gut microbiomes across 141 studies identified 15 microbial taxa simultaneously enriched in aging and depleted in…
Epigenetics rarely generates headlines outside specialist circles, yet this particular discovery touches something with direct health relevance: the molecular…
Understanding what actually executes p53's tumor-suppressing and aging-related commands inside living organisms—not just in cell cultures—has been one of…
Every cell in the human body depends on microscopic protein highways called microtubules to move cargo, divide chromosomes, and generate mechanical force…
The assumption that rapid long-range electrical signaling is exclusive to neurons may need fundamental revision. Evidence that ordinary skin and tissue lining…
As blood cancer survival rates climb, a critical and underappreciated threat is emerging in the decades that follow remission: cardiovascular disease. For the…
For the roughly 18 million cancer survivors in the United States alone, crossing the finish line of active treatment is not the end of the health story — it…
Young adults diagnosed with fibrolamellar carcinoma face a frustrating paradox: their tumors carry a highly recognizable oncogenic signature, yet the immune…